HEALTHCARE NEWS - AN OVERVIEW

Britain’s drug regulator authorized the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it immediately after an unbiased watchdog company said the treatment isn’t well worth the Price to taxpayersTwo men and women sharing a house caught the virus with no acknowledged exposure to animals. In excess of thirty hum